Weiqiang Lu

32PUBLICATIONS
67CO-AUTHORS
Molecular targetsBiologically active moleculesMolecular medicineNuclear physicsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 08, 2026
Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy.

|Mar 30, 2026
Target-Centric Multiplexed Screening of an Herbal Extract Identifies a Novel Dual A2A/A2B Receptor Antagonist for Cancer Immunotherapy.

Hongyue Liu, Xinyu Yang, Jingyi Xu

|Mar 20, 2026
Discovery of 1,2,3,4-Tetrahydrochromeno[3,4-c]pyridin-5-one Derivatives as Novel MTHFD Inhibitors for the Treatment of Acute Myeloid Leukemia.

Hao Lin, Xiangli He, Bin Sun

|Dec 15, 2025
Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression.

Weiqiang Lu, Jiayan Cui, Wanyan Wang

|Nov 10, 2025
Exercise increases bone mass by lactate/Gpr81 signaling pathway.

Yilan Guo, Liang He, Aochuan Xue

|Mar 18, 2025
Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics.

Longliang Qiao, Lingxue Niu, Zhihao Wang

Pageof 6

Frequent Collaborators

18 joint publications

Mingyao Liu

6 joint publications

Hankun Zhang

6 joint publications

Feixiong Cheng

6 joint publications

Qiansen Zhang